Xstrahl is going to ESTRO 37; join us at Booth 5100
Xstrahl is delighted to invite you to ESTRO 37 taking place in Barcelona on 20 – 23 April.
Join us at Booth 5100 to explore innovative applications of X-ray technology, where we will be showcasing the latest achievements in the medicine and life science. Our medical team will be highlighting our Xstrahl 200 and new RADiant systems.
RADiant is the next evolution in skin cancer removal and keloid treatment. It is a compact and ergonomic superficial X-Ray therapy system, intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary skin cancers and keloids. Utilising trusted and clinically proven low energy photons, in a dedicated treatment system RADiant provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer and superficial lesions, especially those found in sensitive areas of the head and neck.
Xstrahl 200 is the only x-ray therapy system manufactured with inbuilt dose control of delivered fractions for total patient safety. Ideal for treating many superficial skin cancers, the Xstrahl 200 X-ray system can also be used to treat dermatological conditions such as psoriasis, and a range of other benign conditions such as Dupuytren’s Contracture, Peyronie’s Disease and Gynecomastia. In addition, the Xstrahl 200 enables orthovoltage therapy for palliative care, including treatment of soft tissue metastases and secondary lesion.
Our guests will also have an opportunity to attend the presentation of Concerto 2.0 – an upgrade to Xstrahl clinical software streamlining the clinical workflow for the entire range of the Xstrahl systems.
The life sciences team will present new CIX Series cabinet irradiators – free standing, self-contained X-ray irradiators designed to facilitate the safe and accurate irradiation of biological samples within a standard laboratory environment.
The Small Animal Radiation Research Platform (SARRP) will once again feature, where we will be happy to share the recent research findings and developments achieved with the help of our state-of-the-art research platform, which makes it possible to perform clinically relevant research in a preclinical laboratory setting.
We look forward to seeing you at ESTRO.
For more information about the event, please visit their website.